AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 266: H28-H35, 1994;
0363-6135/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kilgore, K. S.
Right arrow Articles by Lucchesi, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kilgore, K. S.
Right arrow Articles by Lucchesi, B. R.

AJP - Heart and Circulatory Physiology, Vol 266, Issue 1 28-H35, Copyright © 1994 by American Physiological Society

ARTICLES

Sulfhydryl compounds, captopril, and MPG inhibit complement-mediated myocardial injury

K. S. Kilgore, J. W. Homeister, P. S. Satoh and B. R. Lucchesi
Department of Pharmacology, University of Michigan Medical School, Ann Arbor 48109-0626.

Factors including complement activation, neutrophil infiltration, and oxygen-derived free radicals have been implicated in the pathogenesis of myocardial tissue injury during ischemia and reperfusion. Certain sulfhydryl-containing compounds have been shown to inhibit complement activation. The sulfhydryl compounds captopril and N-(2-mercaptopropionyl)-glycine (MPG) are antioxidant compounds that previously have been shown to protect the myocardium from ischemia and reperfusion-induced damage. In this study, captopril (an angiotensin-converting-enzyme inhibitor; ACEI) and MPG, and the non-sulfhydryl compound enalaprilat (also an ACEI) were tested for their ability to protect the isolated perfused rabbit heart against complement-induced injury. Both captopril and MPG protected hearts against complement-mediated increases in left ventricular end-diastolic pressure and increases in coronary arterial perfusion pressure in a concentration-dependent manner, whereas enalaprilat was not protective. The ability of these compounds to inhibit complement activation also was tested using an in vitro complement-mediated red blood cell hemolysis assay. These findings offer additional insight as to the mechanism whereby captopril, MPG, and possibly other sulfhydryl compounds, may be acting to provide cytoprotection during myocardial ischemia and reperfusion.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
E. J. Tanhehco, K. Yasojima, P. L. McGeer, R. A. Washington, and B. R. Lucchesi
Free radicals upregulate complement expression in rabbit isolated heart
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H195 - H201.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. J. Tanhehco, K. Yasojima, P. L. McGeer, and B. R. Lucchesi
Acute Cocaine Exposure Up-Regulates Complement Expression in Rabbit Heart
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 201 - 208.
[Abstract] [Full Text]

Home page
 HypertensionHome page
M. Barbagallo, L. J. Dominguez, and L. M. Resnick
Protective Effects of Captopril Against Ischemic Stress : Role of Cellular Mg
Hypertension, October 1, 1999; 34(4): 958 - 963.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. S. Kilgore, K. B. Naylor, E. J. Tanhehco, J. L. Park, E. A. Booth, R. A. Washington, and B. R. Lucchesi
The Semisynthetic Polysaccharide Pentosan Polysulfate Prevents Complement-Mediated Myocardial Injury in the Rabbit Perfused Heart
J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 987 - 994.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online